| Entry |
|
|---|
| Name |
Eglumetad (USAN);
Eglumegad hydrate |
|---|
| Formula |
C8H11NO4. H2O
|
|---|
| Exact mass |
203.0794
|
|---|
| Mol weight |
203.1925
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antianxiety, Smoking cessation adjunct, Metabotropic glutamate receptor agonist |
|---|
| Comment |
Treatment of general anxiety disorders and smoking cessation
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Metabotropic glutamate receptor family
Glutamate (metabotropic)
GRM2
D03966 Eglumetad (USAN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 14
1 O0 O 20.1600 -21.5600
2 C1y C 11.9000 -20.5100
3 C1y C 13.1600 -21.2100
4 C1y C 13.1600 -19.8100
5 C1z C 14.4900 -21.6300
6 C1x C 15.3300 -20.5100
7 C1x C 14.4900 -19.3900
8 C6a C 10.5000 -20.4400
9 O6a O 9.8000 -21.6300
10 O6a O 9.8000 -19.2500
11 N1a N 14.4900 -23.0300
12 C6a C 15.6800 -22.3300
13 O6a O 16.8700 -21.6300
14 O6a O 15.6800 -23.7300
BOND 14
1 2 3 1
2 3 4 1
3 4 2 1
4 3 5 1
5 5 6 1
6 6 7 1
7 4 7 1
8 2 8 1 #Up
9 8 9 2
10 8 10 1
11 5 11 1 #Down
12 5 12 1 #Up
13 12 13 1
14 12 14 2
|
|---|
